摘要
近年来的研究对于急性髓系白血病(AML)发病机制的理解已经有了显著的进步,导致AML发病的许多分子学异常逐渐明晰,因此对于AML的本质认识越来越深刻。与此同时大量临床试验的开展也获得了相当的成功,AML的诊治方案已经进展到了个体化阶段。
With the identification of numerous molecular abnormalities that may be responsible for leukemogenesis,the mechanisms leading to the development of acute myeloid leukemia (AML) has been maken remarkably progress,and there are more and more profound understandings of the nature of AML.At the same time a large number of clinical trials conducted has reaped considerable success,the diagnosis and treatment of AMLhas advanced to individual phase.
出处
《实用医院临床杂志》
2010年第2期46-50,共5页
Practical Journal of Clinical Medicine
关键词
急性髓系白血病
个体化治疗
预后评估
Acute myeloid leukemia
Individualized therapy
Assessment of prognosis